We have very little insider data for IMS Health Holdings, Inc. so far: the most recent filing dates from 7 July 2017. With so few records, no pattern can be drawn yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2015 · cache
25 of 51 declarations
IMS Health Holdings, Inc. is a company that provides data and analytics for the healthcare sector. It assists pharmaceutical and biotechnology companies in making informed decisions through accurate market insights.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2015 | 2.92 bn USD | 417.0 m USD | 1.23 USD | 10-K |
| Dec 2014 | 2.64 bn USD | -189.0 m USD | -0.59 USD | 10-K |
| Dec 2013 | 2.54 bn USD | 82.0 m USD | 0.29 USD | 10-K |
| Dec 2012 | 2.44 bn USD | -42.0 m USD | -0.15 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.